Search alternatives:
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
-
961
-
962
-
963
-
964
-
965
Changes associated with kidney fibrosis and effects of MN705 treatment on TGF-
Published 2025Subjects: -
966
-
967
-
968
-
969
-
970
HRMECs treated with 3-Deazaneplanocin A (DZNep) chemical inhibitor demonstrated increased miR-200b and decreased VEGF expression.
Published 2015“…[NG = 5mM D-glucose, HG = 25mM D-glucose, NG+DMSO = 5mM D-glucose + 0.05% DMSO, HG+DMSO = 25mM D-glucose + 0.05% DMSO, NG+DZNEP = 5mM D-glucose + 5μM DZNep, HG+DZNEP = 25mM + 5μM DZNep; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to β-actin for VEGF and U6 for miR-200b, expressed as a fold change of NG].…”
-
971
Changes of anti-oxidative enzyme and oxidative stress after in a mouse model of kidney fibrosis.
Published 2025Subjects: -
972
-
973
-
974
Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF-
Published 2025Subjects: -
975
-
976
-
977
-
978
-
979
-
980